SpringWorks sells two rare tumors drugs in the US and has two precision oncology drugs in early-stage development.

An anchor announcement at today's TELUS Health Annual Conference, TELUS Health revealed the results of its 2025 Drug Data Trends and National Benchmarks Report, offering an industry-wide snapshot of ...